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Abstract
Background: Sentinel lymph node (SLN) procedure is now a widely accepted method of LN
staging in selected invasive breast cancers (unifocal, size ≤ 2 cm, clinically N0, without previous
treatment). Complete axillary clearance is no longer needed if the SLN is negative. However, the
oncological safety of this procedure remains to be addressed in randomized clinical trials. One main
pitfall is the failure to visualize SLN, resulting in incorrect tumor staging, leading to suboptimal
treatment or axillary recurrence. Operative gamma cameras have therefore been developed to
optimize the SLN visualization and the quality control of surgery.
Case presentation: A 44-year-old female patient with a 14-mm infiltrative ductal carcinoma
underwent the SLN procedure. An operative gamma camera was used during and after the surgery.
The conventional lymphoscintigraphy showed only one SLN, which was also detected by the
operative gamma camera, then removed and measured (9.6 kBq). It was analyzed by frozen
sections, showing no cancer cells. During this analysis, the exploration of the axillary area with the
operative gamma camera enabled the identification of a second SLN with low activity (0.5 kBq) that
conventional lymphoscintigraphy, surgical probe and blue staining had failed to visualize.
Histological examination revealed a macrometastasis. Axillary clearance was then performed,
followed by a postoperative image proving that no SLN remained. Therefore, the use of the
operative gamma camera prevented an under-estimation of staging which would have resulted in a
suboptimal treatment for this patient.
Conclusion: This case report illustrates that an efficient operative gamma camera may be able to
decrease the risk of false negative rate of the SLN procedure, and could be an additional tool to
control the quality of the surgery.
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Background
As lymph node (LN) metastasis is one of the most impor-
tant prognostic factors for survival, the assessment of
regional LN is essential in the staging of breast cancer,
ascertaining a prognosis, and determining of optimal
adjuvant treatments. The sentinel node (SLN) procedure
consists of recognizing and removing the first LN that fil-
ter lymphatic fluid from the tumor. It is now a widely
accepted method of LN staging in selected invasive breast
cancer (unifocal, size ≤ 2 cm, clinically N0, without previ-
ous treatment). The complete axillary clearance is no
longer needed if the SLN is normal [1]. However, its onco-
logical safety remains to be addressed in randomized clin-
ical trials [2]. One main pitfall is the failure to visualize
SLN, resulting in incorrect tumor staging, leading to sub-
optimal treatment or axillary recurrence. Several factors
including advanced age, high body mass index, massive
metastasis invasion [3] or tumor location other than
upper outer quadrant [4] may contribute to SLN non-vis-
ualization.
Operative gamma cameras (OGC) have therefore been
developed to optimize the SLN visualization and the qual-
ity control of surgery [5-10]. In our ongoing clinical trial
[11], an OGC, named CarolIReS, with a current field of
view (FOV) of 50 × 50 mm2 is being used [12]. It is made
of a lead parallel collimator, a thin Gd2SiO5:Ce scintillat-
ing crystal and a multianode photomultiplier (10 mm
spatial resolution and 2.2 cps.kBq-1 sensitivity for the
99mTc). We present the first case in which OGC, used at the
end of the surgery, enabled the detection of a residual
metastatic SLN.
Case presentation
A 44-year-old female patient with a 14 mm infiltrative
ductal carcinoma, Scarf-Bloom-Richardson grade 2 (diag-
nosed by core biopsy) was enrolled in the clinical study
[11] after informed consent had been obtained. She was
free of chemotherapy, loco-regional radiotherapy, preva-
lent axillary LN and her body mass index was normal (21
kg/m2). The tumor was located in the upper outer quad-
rant of the left breast. The SLN procedure was initiated the
day prior to the surgery using 4 subareolar injections of
rhenium sulfur colloidal and technetium (99mTc) (0.4 ml,
22 MBq (595 μCi), Cis bio international®, France). Scinti-
graphic images (anterior, lateral and oblique views),
obtained 3 hours after rhenium sulfur injections with a
conventional gamma camera (Hélix®, Elscint, Haïfa),
showed one SLN (figure 1). Immediately before surgery,
when the patient was in operative position, four images (2
minutes data acquisition each) were obtained with the
OGC to map the full axillary area (figure 2 represents a
picture of the OGC). The precise localization of this SLN
and an estimation of its depth were determined from the
data by using the width of the image cumulative profiles
(figure 3).
The surgery began with 4 subareolar injections of Methyl-
ene Blue (Lab Aguettant®, Lyon, France), and the search
for the SLN was carried out using the CarolIReS intra-
operative probe [13], which detected only one SLN. This
SLN was blue stained and its measured activity was 9.6
The anterior view of the conventional lymphoscintigraphy  shows one SLN indicated by the yellow arrow Figure 1
The anterior view of the conventional lymphoscintigraphy 
shows one SLN indicated by the yellow arrow. The purple 
arrow indicates the injection site.
Picture of the CarolIReS gamma camera built at the IPHC,  Strasbourg, France Figure 2
Picture of the CarolIReS gamma camera built at the IPHC, 
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kBq (0.26 μCi). It was subsequently submitted for frozen
section analysis, which showed the absence of cancer
cells. During this analysis, the axillary area was thor-
oughly palpated by the surgeon and no nodes showing
signs of extensive tumor involvement were identified. A
second exploration of this area was then performed using
the OGC enabling the identification of a second SLN
located at a distance from the first one of less than the spa-
tial resolution of the OGC (figure 4). This SLN was not
stained and had a low activity of 0.5 kBq (0.01 μCi) con-
centrated in its hilum.
The histological examination revealed an 8-mm mac-
rometastasis occupying the whole structure of this SLN
without residual sinusoidal macrophages (figure 5). Axil-
lary clearance was then performed and each of the 11 LN
removed was negative. Axillary surgery was followed by
lumpectomy. A postoperative OGC image proved that no
SLN remained (figure 6) and was considered a quality
control document.
Discussion
This is the first published case in which an OGC enabled
the detection of a non-stained metastatic SLN, which was
neither diagnosed by conventional lymphoscintigraphy,
nor by operative probe, nor by palpation of the axillary
area performed by an experienced surgeon. This can be
partially explained by the very low activity of this SLN (0.5
kBq). It corresponds to 0.02‰ of the injected dose, which
is inferior to our mean measured value of 0.5‰. Meta-
static SLN sometimes have very low activity, because they
contain numerous cancer cells and few macrophages, the
latter being the cells that retain radiocolloïdes [14]. In our
experience, the activity of metastatic SLN is less than 10
kBq in more than half of the cases. So the detection effi-
ciency of OGC must be good, and that of the one we used
in this reported case was 2.2 cps.kBq-1. Future clinical tri-
als will have to determine whether or not there is an infe-
rior threshold for the activity of the SLN which should be
removed.
Preoperative image of the axillary area obtained with the CarolIReS gamma camera Figure 3
Preoperative image of the axillary area obtained with the CarolIReS gamma camera. The x and y cumulative profiles (red stars) 
are used to determine the planar coordinates and the anatomical depth of the first SLN.World Journal of Surgical Oncology 2007, 5:132 http://www.wjso.com/content/5/1/132
Page 4 of 6
(page number not for citation purposes)
In addition, ongoing trials using OGC will have to evalu-
ate if the latter lead to unnecessary SLN removal and
increase morbidity or if they decrease the false negative
rate (FNR). However, it has been demonstrated that the
identification of multiple SLN, when present, reduced the
FNR. For example, Goyal et al. [15] studied a series of 803
patients with breast cancer who underwent successful SLN
procedure followed by an axillary clearance. In patients
who had one SLN harvested, the FNR was 10%, compared
with 1% in patients who had 3 or more SLN removed. Fac-
tors associated with finding multiple SLN (62.4% of
patients) were age less than 50 years, low body mass
index, tumor in the outer half of the breast, SLN visualiza-
tion on lymphoscintigraphy and an interval of 12 hours
or less between radioisotope injection and SLN proce-
dure. For 99.6% of node-positive tumors, metastases were
detected within the first 4 SLN removed and the authors
suggested that the removal of more than 4 SLN was
unnecessary [15]. Ongoing clinical trials will have to dis-
cuss precisely the usefulness of OGC according to the
number of SLN found with conventional procedures (less
than or equal to 4 or greater than 4).
Ductal breast carcinoma metastasis destroying nodal archi- tecture (Hematoxilin and Eosin ×20) Figure 5
Ductal breast carcinoma metastasis destroying nodal archi-
tecture (Hematoxilin and Eosin ×20). Inset: metastatic cells 
(Hematoxilin and Eosin ×200) in the second SLN.
Peroperative image of the axillary area obtained with the CarolIReS gamma camera Figure 4
Peroperative image of the axillary area obtained with the CarolIReS gamma camera. The x and y cumulative profiles (red stars) 
are used to determine the planar coordinates and the anatomical depth of the second SLN.World Journal of Surgical Oncology 2007, 5:132 http://www.wjso.com/content/5/1/132
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Conclusion
This case report illustrates that an efficient OGC may be
able to decrease the risk of FNR of the SLN procedure, and
could be an additional tool to control the quality of the
surgery. But a precise evaluation of OGC should be based
upon data from a large number of patients. Our ongoing
clinical trial [11] will be soon published and a new clini-
cal trial, including 100 breast cancer patients, will begin at
the end of 2007 to evaluate the usefulness of the new
CarolIRes OGC (FOV : 100 × 100 mm2) in the SLN proce-
dure.
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